Login / Signup

SMYD2-mediated TRAF2 methylation promotes the NF-κB signaling pathways in inflammatory diseases.

Weijun WuJinghuan WangChenxi XiaoZhenghua SuHaibi SuWen ZhongJianchun MaoXinhua LiuYi Zhun Zhu
Published in: Clinical and translational medicine (2022)
Our data uncovered an unprecedented cytoplasmic protein network that employed methylation of TRAF2 for the maintenance of NF-κB activation during inflammatory diseases.
Keyphrases